Gary Bucher, M.D.

For over 35 years, Dr. Bucher has been a leader in clinical care and research with HIV/ AIDS patients. He has felt the need to be on the forefront of advances and care for PLWH. Dr. Bucher saw the rates of anal cancer increasing in PLWH, MSM and other high-risk groups.

Dr. Bucher started referring patients for work up for abnormal anal pap smears (anal cytology) to colorectal surgeons. He soon found out that his patients were not getting the appropriate evaluation with high resolution anoscopy (HRA). His patients were examined with a rectal exam and a standard plain anoscopy. Subsequently, they were told that everything was normal when they could have had anal precancer that was not seen because an HRA was not performed. His patients felt a false sense of security that they were being evaluated properly and that all was normal.

Publications and Articles

July 11, 2024

What Next -Stigma Stops Anal Cancer Screenings

July 9, 2024

Patient Worthy – Rare Community Profiles: Stigma Stops Anal Cancer Screenings, But Dr. Gary Bucher is Ready to Start Conversations on the Importance of Anal Health

May 15, 2024

Chronilce Illinois – High-risk groups targeted for anal cancer screenings

February 29, 2024

Healthline – Best At-Home STD Kits for 2024

Profiles, Awards, and Honors

Dr. Gary Bucher, MD, FAAFP, is a highly specialized anal health provider and the founder and Medical Director of the Anal Dysplasia Clinic MidWest. His practice specifically focuses on anal health issues related to HPV, catering to both men and women.

Dr. Bucher graduated from the University of Missouri-Kansas City School of Medicine in 1989 and is certified by the National Board of Physicians and Surgeons. He also holds a fellowship with the American Academy of Family Physicians. In addition to his clinical practice, Dr. Bucher serves as a Adjunct Faculty of Family Medicine at Rush Medical College.

Throughout his career, he has shown a strong commitment to the HIV/AIDS community, publishing and presenting research both nationally and internationally since the early days of the epidemic. His clinical interests include treating patients with high-grade squamous intraepithelial neoplasia (HSIL), abnormal anal pap smears, anal condyloma, and persistent anal symptoms.

Dr. Bucher has undergone specialized training in the office-based evaluation and treatment of anal HSIL using High Resolution Anoscopy (HRA). He holds Certificates of Proficiency in HRA and the treatment of HSIL. Additionally, he is certified to provide HRA services for clinical trials under the AIDS Clinical Trial Group (ACTG) and the AIDS Malignancy Consortium (AMC).

Scientific Meeting Presentations

ORAL PRESENTATIONS

POSTER PRESENTATIONS